Security key
18978H508
CNS Pharmaceuticals, Inc. - Common Stock (CNSP)
CUSIP: 18978H508
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 1,614,040
- Total 13F shares
- 24,616
- Share change
- +24,603
- Total reported value
- $221,544
- Price per share
- $9.00
- Number of holders
- 8
- Value change
- +$221,533
- Number of buys
- 8
- Number of sells
- 1
Report period
Q3 2025
Institutions
8
Top holders
8
CNSP full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
CNS Pharmaceuticals, Inc. SEC filings
CNS Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 18978H508
Recent filing periods:
Top shareholders of CNSP - CNS Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
5%
from 13D/G
|
406,000
|
$334,950 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
13
|
$11 | — | 30 Jun 2025 | |
| Waldemar Priebe |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
156,807
|
$198,486 | — | 06 Dec 2022 | |
| Cortice Biosciences, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
573,368
|
$172,010 | — | 30 Jul 2024 | |
| Carl Anthony Evans |
3/4/5
|
Director |
—
mixed-class rows
|
501,001
mixed-class rows
|
$54,165 | — | 08 Apr 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
32,103
|
$26,485 | — | 30 Jun 2025 | |
| Virtu Financial LLC |
13F
|
Company |
—
class O/S missing
|
23,348
|
$19,000 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
17,871
|
$14,743 | — | 30 Jun 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
15,633
|
$12,897 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
—
class O/S missing
|
10,863
|
$8,000 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
6,738
|
$5,559 | — | 30 Jun 2025 | |
| BARRETT & COMPANY, INC. |
13F
|
Company |
—
class O/S missing
|
100
|
$83 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
49
|
$40 | — | 30 Jun 2025 | |
| MAI Capital Management |
13F
|
Company |
—
class O/S missing
|
40
|
$33 | — | 30 Jun 2025 | |
| Andrzej Andraczke |
3/4/5
|
Director |
—
class O/S missing
|
45,428
|
— | — | 21 Sep 2023 |
Institutional Holders of CNS Pharmaceuticals, Inc. - Common Stock (CNSP) as of Q3 2025
As of 30 Sep 2025,
CNS Pharmaceuticals, Inc. - Common Stock (CNSP) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,616 shares.
The largest 8 holders included
DRW Securities, LLC, UBS Group AG, MORGAN STANLEY, BARRETT & COMPANY, INC., BANK OF AMERICA CORP /DE/, MAI Capital Management, CITIGROUP INC, and DANSKE BANK A/S.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
1
Q3 2025 holders
8
Holder diff
7
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.